Therapixel Case Study: Improved Radiologist Performance with MammoScreen 3D

DomAIn Knowledge

Ferrum Health partners with best-in-class AI providers offering solutions designed to reduce radiology workload and improve patient care.

Therapixel Case Study: Improved Radiologist Performance


One in eight women will develop breast cancer in their lifetime. Early detection of breast cancer is key before the cancer metastasizes. A clinical study compared radiologists’ performance reading with and without MammoScreen® 3D.

Clinical case

After a false negative case, the original reader found the cancer a year after the initial mammogram. A linear microcalcification cluster in the posterior medial right breast was detected. The lesion was flagged by MammoScreen via tomosynthesis a year earlier with a score of 7. During a reader study, 5 radiologists recalled this case unassisted, with an additional 12 recalling the case utilizing MammoScreen.


The Therapixel Study suggests the use of AI-guided decision-making support, such as Mammoscreen, is reliable in assisting in the early detection of breast cancer. 

Interested in deploying Mammoscreen at your health facility?

Contact the Ferrum Health team to learn more.


Request More Information

Fill in the details below to request more information or a demo of our AI platform. Our team is standing by and ready to help!